JPH04235905A - Cosmetics - Google Patents
CosmeticsInfo
- Publication number
- JPH04235905A JPH04235905A JP3013832A JP1383291A JPH04235905A JP H04235905 A JPH04235905 A JP H04235905A JP 3013832 A JP3013832 A JP 3013832A JP 1383291 A JP1383291 A JP 1383291A JP H04235905 A JPH04235905 A JP H04235905A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- melanin production
- weight
- lactococcus
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 18
- 239000000284 extract Substances 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 241000194036 Lactococcus Species 0.000 claims abstract description 8
- 241000194017 Streptococcus Species 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims abstract description 5
- 239000004480 active ingredient Substances 0.000 claims abstract description 4
- 230000008099 melanin synthesis Effects 0.000 claims description 21
- 230000001580 bacterial effect Effects 0.000 claims description 20
- 239000003112 inhibitor Substances 0.000 claims description 16
- 102000003425 Tyrosinase Human genes 0.000 abstract description 15
- 108060008724 Tyrosinase Proteins 0.000 abstract description 15
- 241000194020 Streptococcus thermophilus Species 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 11
- 230000002401 inhibitory effect Effects 0.000 abstract description 11
- 241000194034 Lactococcus lactis subsp. cremoris Species 0.000 abstract description 5
- 235000014962 Streptococcus cremoris Nutrition 0.000 abstract description 5
- 229940124200 Melanin inhibitor Drugs 0.000 abstract description 3
- 241000894006 Bacteria Species 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 description 22
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 239000002609 medium Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 239000008103 glucose Substances 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 230000002087 whitening effect Effects 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000401 methanolic extract Substances 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000012228 culture supernatant Substances 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 241000194035 Lactococcus lactis Species 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 235000014897 Streptococcus lactis Nutrition 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 239000007640 basal medium Substances 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- OIPPWFOQEKKFEE-UHFFFAOYSA-N orcinol Chemical compound CC1=CC(O)=CC(O)=C1 OIPPWFOQEKKFEE-UHFFFAOYSA-N 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 229960004441 tyrosine Drugs 0.000 description 2
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 238000000035 BCA protein assay Methods 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- VLSOAXRVHARBEQ-UHFFFAOYSA-N [4-fluoro-2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=C(F)C=C1CO VLSOAXRVHARBEQ-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940089837 amygdalin Drugs 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- WWAABJGNHFGXSJ-UHFFFAOYSA-N chlorophenol red Chemical compound C1=C(Cl)C(O)=CC=C1C1(C=2C=C(Cl)C(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 WWAABJGNHFGXSJ-UHFFFAOYSA-N 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- YXVFQADLFFNVDS-UHFFFAOYSA-N diammonium citrate Chemical compound [NH4+].[NH4+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O YXVFQADLFFNVDS-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000021105 fermented cheese Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 230000015784 hyperosmotic salinity response Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000004694 pigment cell Anatomy 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- -1 polyoxyethylene Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 229940120668 salicin Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 108010050327 trypticase-soy broth Proteins 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Abstract
Description
【0001】0001
【産業上の利用分野】本発明はメラニン生成抑制剤に関
し、更に詳細には優れたチロシナーゼ活性阻害作用を有
するメラニン生成抑制剤及びこれを含有する化粧料に関
する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a melanin production inhibitor, and more particularly to a melanin production inhibitor having an excellent tyrosinase activity inhibitory effect and a cosmetic containing the same.
【0002】0002
【従来の技術】日焼け等によりヒトの肌が黒く変色する
のは、表皮の基底層に存在する色素細胞中でメラニンが
合成されることが原因とされている。メラニンは、酸化
酵素であるチロシナーゼがアミノ酸の一種であるチロシ
ンを酸化重合させることにより合成される。2. Description of the Related Art The dark discoloration of human skin caused by sunburn and the like is said to be caused by the synthesis of melanin in pigment cells present in the basal layer of the epidermis. Melanin is synthesized by oxidative polymerization of tyrosine, a type of amino acid, by tyrosinase, an oxidizing enzyme.
【0003】従来、このチロシナーゼ活性を阻害するこ
とによりメラニンの生成を抑制する物質としては、ビタ
ミンC、システイン、アルブチン、コウジ酸、グルタチ
オン、ハイドロキノンなどが知られている。また、天然
物由来のメラニン生成抑制物質としては、セリ科植物抽
出物、胎盤抽出物などが知られている。Conventionally, vitamin C, cysteine, arbutin, kojic acid, glutathione, hydroquinone, and the like have been known as substances that inhibit melanin production by inhibiting tyrosinase activity. Furthermore, as melanin production-inhibiting substances derived from natural products, extracts of plants belonging to the Umbelliferae family, extracts of placenta, and the like are known.
【0004】0004
【発明が解決しようとする課題】しかしながら、これら
従来のメラニン生成抑制剤は一般に安定性が悪く、また
その効果が十分でなかったり、安全性に問題がある場合
もあり、必らずしも十分満足できるものではなかった。
従って、安定性が良く、しかも安全性が高く、強力なメ
ラニン生成抑制作用を有し、かつ化粧料への配合性の良
好なメラニン抑制剤及びこれを配合した化粧料の開発が
望まれていた。[Problems to be Solved by the Invention] However, these conventional melanin production inhibitors generally have poor stability, may not be sufficiently effective, or may have safety issues, and are not always sufficient. It wasn't satisfying. Therefore, it has been desired to develop a melanin inhibitor that is stable, highly safe, has a strong melanin production inhibiting effect, and has good incorporation into cosmetics, and a cosmetic containing the melanin inhibitor. .
【0005】[0005]
【課題を解決するための手段】かかる実情において、本
発明者らは鋭意検討してきた結果、発酵乳、チーズのス
ターターとして利用されているストレプトコッカス属又
はラクトコッカス属の特定の微生物の菌体抽出物が極め
て優れたチロシナーゼ活性阻害作用を有し、かつ安全性
も高く、広く化粧料に配合できることを見出し、本発明
を完成した。[Means for Solving the Problems] Under these circumstances, the present inventors have made extensive studies and have found that a bacterial cell extract of a specific microorganism belonging to the genus Streptococcus or Lactococcus, which is used as a starter for fermented milk and cheese. The present invention was completed based on the discovery that the compound has an extremely excellent tyrosinase activity inhibiting effect, is highly safe, and can be widely incorporated into cosmetics.
【0006】すなわち、本発明はストレプトコッカス属
又はラクトコッカス属の菌体より水又はアルコールで抽
出した抽出物を有効成分とするメラニン生成抑制剤、及
びこれを含有する化粧料を提供するものである。That is, the present invention provides a melanin production inhibitor whose active ingredient is an extract extracted from cells of the genus Streptococcus or Lactococcus with water or alcohol, and cosmetics containing the same.
【0007】本発明のメラニン生成抑制剤は、ストレプ
トコッカス属又はラクトコッカス属の菌体より水又はア
ルコールで抽出することにより製造される。The melanin production inhibitor of the present invention is produced by extracting cells of the genus Streptococcus or Lactococcus with water or alcohol.
【0008】本発明に用いられる菌体としては、ストレ
プトコッカス属又はラクトコッカス属に属する微生物で
あれば特に制限されないが、ストレプトコッカス・サー
モフィラスYIT2001 株(ストレプトコッカス・
サーモフィラスYIT2001 株は、ストレプトコッ
カス・サーモフィラス ST−1 株とも称する)又は
ラクトコッカス・ラクチス・サブスピーシーズ・クレモ
リスYIT2058 株が特に好ましい。The microorganism used in the present invention is not particularly limited as long as it belongs to the genus Streptococcus or Lactococcus, but Streptococcus thermophilus strain YIT2001 (Streptococcus thermophilus)
Thermophilus YIT2001 strain (also referred to as Streptococcus thermophilus ST-1 strain) or Lactococcus lactis subsp. cremoris YIT2058 strain is particularly preferred.
【0009】ストレプトコッカス・サーモフィラスYI
T2001 株及びラクトコッカス・ラクチス・サブピ
ーシーズ・クレモリスYIT2058 株の菌学的性質
は以下の通りである。Streptococcus thermophilus YI
The mycological properties of the T2001 strain and Lactococcus lactis subspecies cremoris YIT2058 strain are as follows.
【0010】(1)ストレプトコッカス・サーモフィラ
スYIT2001 株
菌形態
グラム陽性球菌嫌気での生育
+カタラーゼ
−溶血性
−
グルコースからのガス産生 −10
℃での生育
−45℃での生育
+6.5 %食塩耐性
−pH9.6 での生育
−40%bil
eでの生育 −脱
脂乳の凝固性
+メチレンブルー
−NH3 生産
−エスクリンの加水分解
−糖発酵性*1:
アラビノース
−キシロース
−ラムノース
−マンノース
−ガラクトース
+シュークロース
+セロビオース
−ラクトース
+トレハロース
−メリビオ
ース −ラフ
ィノース −
メレチトース
−マンニトール
−ソルビトール
−グルコース
+−は陰性
+は陽性
*1:糖発酵性状試験の基礎培地は指示薬としてCPR
(クロロフェノールレッド)を含むILS 培地を基
本としたものを使用した。(1) Streptococcus thermophilus YIT2001 strain morphology
Growth of Gram-positive cocci anaerobically
+ catalase
-hemolytic
−
Gas production from glucose -10
Growth at °C
Growth at -45℃
+6.5% salt tolerance
-Growth at pH 9.6
-40%bil
Growth in e - Coagulability of skim milk
+methylene blue
-NH3 production
-Hydrolysis of aesculin
-Sugar fermentability *1: Arabinose
-xylose
−Rhamnose
-mannose
-galactose
+Sucrose
+Cellobiose
-lactose
+Trehalose -Melibiose -Raffinose -
meletitose
-Mannitol
-Sorbitol
-glucose
+ - is negative + is positive *1: The basal medium for sugar fermentation property test is CPR as an indicator.
An ILS medium containing (chlorophenol red) was used.
【0011】(2)ラクトコッカス・ラクチス・サブス
ピーシーズ・クレモリスYIT2058 株菌形態
グラム
陽性球菌カタラーゼ
−グルコースからのガス産生
−10℃での増殖性
+45℃での増殖性
−脱脂
乳の凝固性
−グルコン酸からのガス産生
−硝酸塩還元
−糖発酵性*2:
アラビノース
−キシロース
−ラムノース
−リボース
−マンノース
+
フルクトース
+ガラクトース
−シュークロース
−マルトース
−セロビオース
+ラクトース
−
トレハロース
−メリビオース
−ラフィノース
−メレチトース
−マンニトール
−ソルビトー
ル −エ
スクリン
−サリシン
−アミグダリン
−ソルボース
−イノシトール
−イヌ
リン
−スターチ
−α−メチル−D−グルコシド
−グルコース
+デキストリン
−グリコーゲン
−−は陰性
+は陽性
*2:糖発酵性状試験の基礎培地は指示薬としてCPR
を含むILS 培地を基本としたものを使用した。(2) Lactococcus lactis subsp. cremoris YIT2058 strain morphology
Gram-positive cocci catalase
- gas production from glucose
Growth at -10℃
Growth at +45°C - Coagulation of skimmed milk
- Gas production from gluconic acid
-Nitrate reduction
-Sugar fermentability *2: Arabinose
-xylose
−Rhamnose
-ribose
−Mannose +
fructose
+galactose
−Sucrose
-maltose
−Cellobiose
+Lactose -
trehalose
−Melibiose
−Raffinose
-Meletitose
-Mannitol
-Sorbitol -Aesculin
- Salicin
-Amygdalin
-Sorbose
-Inositol -Inulin
−Starch
-α-methyl-D-glucoside
-glucose
+dextrin
-Glycogen
-- is negative + is positive *2: The basal medium for sugar fermentation property test is CPR as an indicator.
A medium based on ILS containing .
【0012】上記菌学的性質を示すストレプトコッカス
・サーモフィラスYIT2001 株は微工研菌寄第1
1891 号(FERM P−11891)として、ラ
クトコッカス・ラクチス・サブスピーシーズ・クレモリ
スYIT2058 株は微工研菌寄第11790 号(
FERM P−11790)として通産省工業技術院微
生物工業技術研究所にそれぞれ寄託した。[0012] Streptococcus thermophilus YIT2001 strain exhibiting the above mycological properties is
No. 1891 (FERM P-11891), Lactococcus lactis subsp.
FERM P-11790) and deposited with the Institute of Microbial Technology, Agency of Industrial Science and Technology, Ministry of International Trade and Industry.
【0013】これらの微生物の菌体は、当該微生物の増
殖に適した条件で培養した後、例えば遠心分離などによ
り培養上清と分離することにより得られる。[0013] The cells of these microorganisms can be obtained by culturing them under conditions suitable for the growth of the microorganisms and then separating them from the culture supernatant by, for example, centrifugation.
【0014】本発明メラニン生成抑制剤の抽出に用いら
れる溶媒は、水又はアルコールであるが、水、メタノー
ル又はこれらの混合溶媒が特に好ましい。抽出は、菌体
を溶媒に懸濁し、室温〜80℃で5分〜1時間静置又は
攪拌することにより行なわれる。抽出後不溶物を除去し
、溶媒を留去すれば、本発明メラニン生成抑制剤が得ら
れる。The solvent used for extracting the melanin production inhibitor of the present invention is water or alcohol, and water, methanol, or a mixed solvent thereof is particularly preferred. Extraction is carried out by suspending the bacterial cells in a solvent and allowing them to stand or stir at room temperature to 80°C for 5 minutes to 1 hour. After extraction, insoluble matters are removed and the solvent is distilled off to obtain the melanin production inhibitor of the present invention.
【0015】かくして得られた本発明メラニン生成抑制
剤は、下記の理化学的性質を有する。
(1)pH
4.0〜6.0
(2)各種反応
フェノール硫酸法 陽
性オルシノール反応
陽性BCAプロテインアッセイ試薬 陽性ローリ
ー反応 陽性
(3)紫外部吸収(溶媒;H 2 O)極大波長257
〜259nm
極小波長232〜234nm(第1図)The thus obtained melanin production inhibitor of the present invention has the following physical and chemical properties. (1) pH 4.0-6.0 (2) Various reactions Phenol sulfuric acid method Positive orcinol reaction
Positive BCA protein assay reagent Positive Lowry reaction Positive (3) Ultraviolet absorption (solvent: H 2 O) maximum wavelength 257
~259nm Minimum wavelength 232-234nm (Figure 1)
【0016】本
発明のメラニン生成抑制剤を配合すれば、優れた美白効
果を有する化粧料が得られる。当該本発明化粧料へのメ
ラニン生成抑制剤の配合量は、化粧料の形態等によって
異なるが、通常0.1 〜10重量%(菌体量換算)が
好ましい。[0016] By incorporating the melanin production inhibitor of the present invention, a cosmetic having an excellent whitening effect can be obtained. The amount of the melanin production inhibitor added to the cosmetic of the present invention varies depending on the form of the cosmetic, etc., but is usually preferably 0.1 to 10% by weight (in terms of bacterial cell amount).
【0017】本発明化粧料の形態としては、クリーム、
乳液、化粧水、油性化粧料、粉末化粧料、パック剤等の
皮膚化粧料が挙げられる。[0017] The cosmetics of the present invention may be in the form of cream,
Examples include skin cosmetics such as emulsions, lotions, oil-based cosmetics, powder cosmetics, and packs.
【0018】なお、本発明化粧料には、上記メラニン生
成抑制剤の他に、非イオン界面活性剤、陰イオン界面活
性剤、両性界面活性剤等の乳化剤;植物油、動物油、高
級脂肪酸、高級アルコール、合成エステル油、ワックス
類、シリコン油等の油性物質;水、香料、防腐剤、顔料
、皮膚栄養剤、皮膚賦活剤、保湿剤、紫外線防止剤、p
H調整剤等を配合することができる。In addition to the above-mentioned melanin production inhibitors, the cosmetic of the present invention also contains emulsifiers such as nonionic surfactants, anionic surfactants, and amphoteric surfactants; vegetable oils, animal oils, higher fatty acids, and higher alcohols. , synthetic ester oils, waxes, silicone oils and other oily substances; water, fragrances, preservatives, pigments, skin nutrients, skin activators, moisturizers, ultraviolet inhibitors, p.
An H adjuster and the like can be added.
【0019】[0019]
【実施例】次に実施例を挙げて本発明を詳細に説明する
。
実施例1
(1)ILS(Glc) 培地(トリプチケース1.0
%,イーストエキス0.5 %,トリプトース0.3
%,リン酸一カリウム0.3 %,リン酸二カリウム
0.3 %,クエン酸二アンモニウム0.2 %,酢酸
ナトリウム0.17%,Salt Sol 0.5%,
ツィーン80 0.1%,L−システイン塩酸塩0.0
2%,グルコース2.0 %)をpH6.8 に調整し
、これを三角フラスコに充填し、121 ℃、15分間
高圧殺菌した後、ストレプトコッカス・サーモフィラス
YIT2001 を接種し、37℃で24時間静置培養
を行った。EXAMPLES Next, the present invention will be explained in detail with reference to Examples. Example 1 (1) ILS (Glc) medium (trypticase 1.0
%, yeast extract 0.5%, tryptose 0.3
%, monopotassium phosphate 0.3%, dipotassium phosphate 0.3%, diammonium citrate 0.2%, sodium acetate 0.17%, Salt Sol 0.5%,
Tween 80 0.1%, L-cysteine hydrochloride 0.0
2%, glucose 2.0%) was adjusted to pH 6.8, filled into an Erlenmeyer flask, autoclaved at 121°C for 15 minutes, inoculated with Streptococcus thermophilus YIT2001, and left at 37°C for 24 hours. Culture was performed.
【0020】ラクトコッカス・ラクチス・サブスピーシ
ーズ・クレモリスYIT2058 はILS(Glc)
培地を用い、30℃で20時間静置培養を行った。Lactococcus lactis subsp. cremoris YIT2058 is an ILS (Glc)
Using the medium, static culture was performed at 30°C for 20 hours.
【0021】培養後、遠心分離機を用いて菌体と培養上
清に分離し、菌体をメタノール溶液に懸濁し、60℃、
10分間、3回抽出を行った後、菌体を除きさらに減圧
下で溶媒を除去し、これを抽出物とした。After culturing, the bacterial cells and culture supernatant are separated using a centrifuge, and the bacterial cells are suspended in a methanol solution and incubated at 60°C.
After extraction was performed three times for 10 minutes, the bacterial cells were removed and the solvent was further removed under reduced pressure to obtain an extract.
【0022】(2)得られた抽出物のメラニン生成抑制
作用を、メラニン生成の酸化酵素であるチロシナーゼ活
性の阻害作用を指標として検討した。(2) The inhibitory effect on melanin production of the obtained extract was examined using the inhibitory effect on tyrosinase activity, which is an oxidase for melanin production, as an indicator.
【0023】試験方法
酵素溶液:チロシナーゼ(4300単位/mg)0.1
mg を蒸留水1mlに溶解する。
基質溶液:L−チロシンを10mMになるように溶解す
る。
緩衝液 :0.4 Mリン酸緩衝液(pH6.8 )
を用いる。Test method Enzyme solution: Tyrosinase (4300 units/mg) 0.1
Dissolve mg in 1 ml of distilled water. Substrate solution: Dissolve L-tyrosine to 10mM. Buffer: 0.4 M phosphate buffer (pH 6.8)
Use.
【0024】試験管に緩衝液0.75ml、酵素溶液0
.5ml 及び被験試料1mlを入れ37℃で10分間
インキュベートした後、あらかじめ37℃でインキュベ
ートしておいた基質溶液0.75mlを添加し15分間
反応させる。反応終了後直ちに分光光度計によって47
5nm における吸光度(B)を測定する。また被験試
料無添加(蒸留水添加)の場合の吸光度(A)を測定し
次式からチロシナーゼ活性の阻害率を算出した。[0024] In a test tube, add 0.75 ml of buffer solution and 0.0 ml of enzyme solution.
.. After adding 5 ml and 1 ml of the test sample and incubating at 37°C for 10 minutes, 0.75 ml of the substrate solution previously incubated at 37°C was added and allowed to react for 15 minutes. Immediately after the completion of the reaction, 47
Measure the absorbance (B) at 5 nm. In addition, the absorbance (A) in the case where no test sample was added (distilled water added) was measured, and the inhibition rate of tyrosinase activity was calculated from the following formula.
【数1】[Math 1]
【0025】試験結果
抽出物のチロシナーゼ阻害活性の濃度依存性を図2に示
した。試料濃度は測定系3mlに含まれる菌体相当量で
表した。Test Results The concentration dependence of the tyrosinase inhibitory activity of the extract is shown in FIG. The sample concentration was expressed as the equivalent amount of bacterial cells contained in 3 ml of the measurement system.
【0026】以上の結果よりチロシナーゼ活性50%阻
害を示した菌体量はストレプトコッカス・サーモフィラ
スYIT2001 は2.9mg 、ラクトコッカス・
ラクチス・サブスピーシーズ・クレモリスYIT205
8は4.6mg であった。From the above results, the amount of bacterial cells that showed 50% inhibition of tyrosinase activity was 2.9 mg for Streptococcus thermophilus YIT2001, and 2.9 mg for Lactococcus thermophilus YIT2001.
lactis subspecies cremoris YIT205
8 was 4.6 mg.
【0027】実施例2
ストレプトコッカス・サーモフィラスYIT2001
をILS(Glc) 培地を用い、37℃で24時間静
置培養を行った。また、ラクトコッカス・ラクチス・サ
ブスピーシーズ・クレモリスYIT2058 はILS
(Glc)培地を用い、30℃で24時間静置培養を行
った。Example 2 Streptococcus thermophilus YIT2001
were statically cultured at 37° C. for 24 hours using ILS (Glc) medium. In addition, Lactococcus lactis subsp. cremoris YIT2058 is an ILS
(Glc) medium was used for static culture at 30° C. for 24 hours.
【0028】培養後、遠心分離を用いて菌体と培養上清
を分離し、菌体を蒸留水に懸濁し、60℃、10分間、
3回抽出を行った後、減圧下で溶媒を除去し、これを抽
出物とした。After culturing, the bacterial cells and culture supernatant were separated using centrifugation, and the bacterial cells were suspended in distilled water and incubated at 60°C for 10 minutes.
After extraction was performed three times, the solvent was removed under reduced pressure to obtain an extract.
【0029】実施例と同様に試験して得られた抽出物の
チロシナーゼ阻害活性の濃度依存性を図3に示した。試
料濃度は測定系3mlに含まれる菌体相当量で表した。FIG. 3 shows the concentration dependence of the tyrosinase inhibitory activity of the extract obtained by testing in the same manner as in the example. The sample concentration was expressed as the equivalent amount of bacterial cells contained in 3 ml of the measurement system.
【0030】以上の結果よりチロシナーゼ活性50%阻
害を示した菌体量はストレプトコッカス・サーモフィラ
スYIT2001 は3.1 mg、ラクトコッカス・
ラクチス・サブスピーシーズ・クレモリスYIT205
8は4.5mg であった。From the above results, the amount of bacterial cells that showed 50% inhibition of tyrosinase activity was 3.1 mg for Streptococcus thermophilus YIT2001, and 3.1 mg for Lactococcus thermophilus YIT2001.
lactis subspecies cremoris YIT205
8 was 4.5 mg.
【0031】実施例3 化粧水
(組 成)
ストレプトコッカス・サーモフィラスYIT2001
1.0重量% 菌体メタノール抽出物(実施例
1)エタノール
10.0重量%1,
3 −ブチレングリコール
2.0重量%ポリオキシエチレン硬化
ヒマシ油(50E.O.) 0.05 重量
%パラオキシ安息香酸メチル
0.1重量%香 料
0.1重量%精 製 水
全体で100 となる量得られた化粧水は、
美白効果に優れ、かつさっぱりとした使用感を有してい
た。Example 3 Lotion (composition) Streptococcus thermophilus YIT2001
1.0% by weight bacterial cell methanol extract (Example 1) ethanol
10.0% by weight1,
3-butylene glycol
2.0% by weight polyoxyethylene hydrogenated castor oil (50E.O.) 0.05% by weight methyl paraoxybenzoate
0.1% by weight fragrance
0.1% by weight purified water
The total amount of lotion obtained is 100.
It had an excellent whitening effect and a refreshing feeling of use.
【0032】実施例4 乳 液
(組 成)
ストレプトコッカス・サーモフィラスYIT2001
5.0 重量% 菌体メタノール抽
出物(実施例1)ステアリン酸
2.0 重量%流動パラフィン
6.0 重量%スクワラン
2.0 重量%ソルビタンモノステアレート
1.
5 重量%ポリオキシエチレンソルビタン
モノステアレート(20E.O.)
2.0 重量%パ
ラオキシ安息香酸ブチル
0.05重量%1,3 −ブ
チレングリコール
3.0 重量%パラオキシ安息香酸
メチル
0.1 重量%香 料
0.15重量%精 製 水
全体で100 となる量得られた乳液は
、美白効果に優れ、かつしっとりとした使用感を有して
いた。Example 4 Emulsion (composition) Streptococcus thermophilus YIT2001
5.0% by weight Bacterial cell methanol extract (Example 1) Stearic acid
2.0% by weight liquid paraffin
6.0 wt% squalane
2.0 wt% sorbitan monostearate
1.
5% by weight polyoxyethylene sorbitan monostearate (20E.O.)
2.0 wt% butyl paraoxybenzoate
0.05% by weight 1,3-butylene glycol
3.0% by weight methyl paraoxybenzoate
0.1% by weight fragrance
0.15% by weight purified water
The emulsion obtained in a total amount of 100 ml had an excellent whitening effect and a moist feeling on use.
【0033】実施例5 クリーム
(組 成)
ストレプトコッカス・サーモフィラスYIT2001
5.0 重量% 菌体メタノール抽
出物(実施例1)流動パラフィン
23.0 重量%ワセリン
7.0 重量%ベヘニルアルコール
1.0 重量%ステアリン酸
2.0 重量%ミツロウ
2.0 重量%ソルビタンモノステアレー
ト
3.5 重量%ポリオキシエチレンソルビタン
モノステアレート(20E.O.)
2.5 重量%パ
ラオキシ安息香酸ブチル
0.05重量%1,3 −ブ
チレングリコール
3.0 重量%パラオキシ安息香酸
メチル
0.1 重量%香 料
0.15重量%精 製 水
全体で100 となる量得られたクリー
ムは、美白効果に優れ、かつ使用感も良好であった。Example 5 Cream (composition) Streptococcus thermophilus YIT2001
5.0% by weight Bacterial cell methanol extract (Example 1) Liquid paraffin
23.0% by weight Vaseline
7.0 wt% behenyl alcohol
1.0 wt% stearic acid
2.0 wt% beeswax
2.0 wt% sorbitan monostearate
3.5% by weight polyoxyethylene sorbitan monostearate (20E.O.)
2.5 wt% butyl paraoxybenzoate
0.05% by weight 1,3-butylene glycol
3.0% by weight methyl paraoxybenzoate
0.1% by weight fragrance
0.15% by weight purified water
The cream obtained in a total amount of 100% had an excellent whitening effect and a good feeling of use.
【0034】[0034]
【発明の効果】本発明のメラニン生成抑制剤は、優れた
チロシナーゼ阻害活性を有し、かつ安全であり、これを
配合した化粧料は優れた美白効果と良好な使用感を有す
るものである。[Effects of the Invention] The melanin production inhibitor of the present invention has excellent tyrosinase inhibitory activity and is safe, and cosmetics containing it have an excellent whitening effect and a good feeling of use.
【図1】本発明メラニン生成抑制剤の紫外部吸収スペク
トルを示す図面である。FIG. 1 is a drawing showing the ultraviolet absorption spectrum of the melanin production inhibitor of the present invention.
【図2】実施例1で得た菌体メタノール抽出物のチロシ
ナーゼ活性阻害率とメタノール抽出した菌体量との関係
を表す図面である。FIG. 2 is a drawing showing the relationship between the tyrosinase activity inhibition rate of the methanol extract of bacterial cells obtained in Example 1 and the amount of bacterial cells extracted with methanol.
【図3】実施例2で得た菌体熱水抽出物のチロシナーゼ
活性阻害率と熱水抽出菌体量との関係を示す図面である
。FIG. 3 is a drawing showing the relationship between the tyrosinase activity inhibition rate of the hot water extract of bacterial cells obtained in Example 2 and the amount of bacterial cells extracted with hot water.
Claims (2)
カス属の菌体より水又はアルコール又はこれらの混合物
で抽出した抽出物を有効成分とするメラニン生成抑制剤
。1. A melanin production inhibitor containing as an active ingredient an extract obtained from bacterial cells of the genus Streptococcus or Lactococcus with water, alcohol, or a mixture thereof.
含有する化粧料。2. A cosmetic containing the melanin production inhibitor according to claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3013832A JPH04235905A (en) | 1991-01-11 | 1991-01-11 | Cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3013832A JPH04235905A (en) | 1991-01-11 | 1991-01-11 | Cosmetics |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04235905A true JPH04235905A (en) | 1992-08-25 |
Family
ID=11844247
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3013832A Pending JPH04235905A (en) | 1991-01-11 | 1991-01-11 | Cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04235905A (en) |
-
1991
- 1991-01-11 JP JP3013832A patent/JPH04235905A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101503979B1 (en) | Skin whitening composition having culture fluid of lactobacillus pentosus strain, and preparation method of the same | |
US20110117227A1 (en) | Cosmetic composition for anti-aging of the skin comprising phaseolus radiatus seed extracts by fermentation and enzyme treatment | |
JP6284881B2 (en) | Compositions containing extracts of continuous or simultaneous fermentation | |
KR20160141205A (en) | The novel strain Lactobacillus sp cosmetic composition containing the culture medium as an active ingredient | |
TW201808324A (en) | Skin external agent for skin whitening comprising an extract of fermented wheat germ | |
KR102227539B1 (en) | Composition of mixed natural fermented extracts | |
KR20030030488A (en) | A cosmetic composition containing an extract of Grifola frondosa | |
KR20210155989A (en) | Composition Comprising Lactobacillus sakei, Culture Fluid, or Culture Fluid Extract thereof with Anti-Wrinkling and Elasticity, Skin Cell Regeneration, and Skin Barrier Property as Active Ingredient | |
KR100206538B1 (en) | Skin whitening cosmetic compositions containing extracts of phellinus linteus powder | |
JPH04264016A (en) | Melanin production inhibitor | |
JPH04282321A (en) | Cosmetic | |
KR102026597B1 (en) | Cosmetic composition for skin whitening comprising a mixture of lactic acid bacteria culture | |
WO2023132415A1 (en) | Composition for skin wrinkle reduction, moisturization, skin barrier enhancement, and skin regeneration, comprising lactic acid bacteria complex strain as active ingredient | |
KR102221097B1 (en) | Cosmetic composition for stress relief and skin barrier improvement | |
KR101173993B1 (en) | An anti-oxidant, anti-inflammatory or anti-allergic composition for cosmetics comprising essentially aplysia kurodai ferments as an effective component and production method of the same | |
JPH04235905A (en) | Cosmetics | |
KR20190036290A (en) | Composition for whitening of skin comprising culture or its extract of pseudoalteromonas carrageenovora | |
US11376212B2 (en) | Skin whitening composition comprising cultured product of Bacillus hwajinpoensis or extract thereof | |
KR19990081226A (en) | Skin cosmetic using natural mushrooms | |
KR102394644B1 (en) | Novel chryseobacterium camelliae dolsongi-ht1 having keratinolytic activity and use thereof | |
JPH05194258A (en) | Inhibitor of melanin pigment synthesis | |
JPH05331036A (en) | Melanism inhibitor and cosmetic containing the same | |
TWI755170B (en) | Use of diaporthe caulivora extract for anti-uv damage and reducing pigmentation | |
EP0503763A1 (en) | Cosmetic material | |
JPH04282320A (en) | Cosmetic |